Mirae Asset Global Investments
FATE icon

Mirae Asset Global Investments’s Fate Therapeutics FATE Stock Holding History

Mirae Asset Global Investments’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,459
Closed -$5.62K – 1669
2025
Q3 		$5.62K Buy
4,459
+31
+0.7% +$33 ﹤0.01% 1609
2025
Q2 		$4.96K Buy
4,428
+486
+12% +$565 ﹤0.01% 1541
2025
Q1 		$3.35K Buy
3,942
+147
+4% +$180 ﹤0.01% 1526
2024
Q4 		$6.11K Buy
+3,795
New +$9.56K ﹤0.01% 1545
2024
Q2 		– Sell
-58,835
Closed -$356K – 1867
2024
Q1 		$356K Buy
+58,835
New +$364K ﹤0.01% 2041
2023
Q3 		– Sell
-71,679
Closed -$342K – 2596
2023
Q2 		$342K Sell
71,679
-20,342
-22% -$112K ﹤0.01% 2125
2023
Q1 		$525K Buy
92,021
+25,198
+38% +$152K ﹤0.01% 1895
2022
Q4 		$674K Buy
66,823
+8,638
+15% +$162K ﹤0.01% 1720
2022
Q3 		$1.3M Buy
58,185
+2,659
+5% +$76.8K ﹤0.01% 1338
2022
Q2 		$1.38M Buy
55,526
+29,785
+116% +$822K ﹤0.01% 1261
2022
Q1 		$998K Buy
25,741
+4,411
+21% +$171K ﹤0.01% 1326
2021
Q4 		$1.25M Buy
21,330
+3,688
+21% +$209K ﹤0.01% 1234
2021
Q3 		$1.04M Buy
17,642
+3,498
+25% +$274K ﹤0.01% 1282
2021
Q2 		$1.23M Buy
14,144
+2,011
+17% +$162K ﹤0.01% 1195
2021
Q1 		$1M Buy
+12,133
New +$1.16M ﹤0.01% 1126

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Mirae Asset Global Investments's FATE Position: Q4 2025 in Review

Mirae Asset Global Investments sold out of Fate Therapeutics (FATE) in Q4 2025, closing a stake of 4,459 shares — an estimated $5.62K sold.

Mirae Asset Global Investments first reported a position in FATE in Q1 2021 and held it in 15 quarters. The position peaked at $1.38M in Q2 2022. 146 funds tracked by Wall St. Rank hold FATE as of Q4 2025.

  • Mirae Asset Global Investments reported no remaining Fate Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 4,459 Fate Therapeutics shares in Q4 2025, an estimated $5.62K.
  • Mirae Asset Global Investments first reported a position in Fate Therapeutics in Q1 2021 and held it in 15 quarters.
  • Mirae Asset Global Investments's Fate Therapeutics position peaked at $1.38M in Q2 2022.
  • 146 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2025.

Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.